慢阻肺合并心衰患者运动不耐受:有氧功能受损的作用
研究纳入51例稳定期COPD合并收缩性心衰患者,行递增心肺运动试验,其中27例ΔV'O2/ΔWR低于正常下限。低ΔV'O2/ΔWR组峰值WR和峰值V'O2分别低约15%和约30%,伴更差的有氧功能、循环效能和通气效率,以及更重的症状负担。
要点
- COPD合并心衰患者中ΔV'O2/ΔWR低于正常下限者运动耐量更差。
- 低ΔV'O2/ΔWR与更差的有氧功能、循环效能和通气效率相关。
- 改善外周肌氧输送或利用可能使这类患者获益。
核心结论
- 心肺-肌肉交互不良导致的有氧功能受损是COPD合并心衰患者运动不耐受的重要决定因素。
研究设计与样本
- 51例临床稳定后的COPD合并收缩性心衰患者完成症状限制性递增心肺运动试验,其中18例无创测量心输出量。
主要发现
- 27例患者ΔV'O2/ΔWR低于正常下限。
- 低ΔV'O2/ΔWR组峰值WR和峰值V'O2分别低约15%和约30%。
- 低ΔV'O2/ΔWR组有更重的日常生活和给定运动强度下症状负担(腿部不适和呼吸困难)。
- 低ΔV'O2/ΔWR组表现更慢的V'O2动力学和更早的无氧阈。
- 低ΔV'O2/ΔWR组氧脉搏、每搏量和心输出量更低。
关键数值与推荐
- 低ΔV'O2/ΔWR组与对照组FEV1和射血分数相似。
- 低ΔV'O2/ΔWR组舒张末容积更高、吸气容量更低、弥散功能更低(p<0.05)。
- 低ΔV'O2/ΔWR组有氧功能和循环效能指标更差(p<0.05)。
- 低ΔV'O2/ΔWR组通气效率和机械性吸气受限更差(p<0.05)。
临床怎么用
- 对COPD合并心衰患者应关注ΔV'O2/ΔWR以识别有氧功能受损者。
- 治疗策略可考虑改善外周肌氧输送和/或利用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Impaired aerobic function is a potential mechanism of exercise intolerance in patients with combined cardiorespiratory disease. We investigated the pathophysiological and sensory consequences of a low change in oxygen uptake (ΔV'O2 )/change in work rate (ΔWR) relationship during incremental exercise in patients with coexisting chronic obstructive pulmonary disease (COPD) and systolic heart failure (HF).After clinical stabilisation, 51 COPD-HF patients performed an incremental cardiopulmonary exercise test to symptom limitation. Cardiac output was non-invasively measured (impedance cardiography) in a subset of patients (n=18).27 patients presented with ΔV'O2 /ΔWR below the lower limit of normal. Despite similar forced expiratory volume in 1 s and ejection fraction, the low ΔV'O2 /ΔWR group showed higher end-diastolic volume, lower inspiratory capacity and lower transfer factor compared to their counterparts (p<0.05). Peak WR and peak V'O2 were ∼15% and ∼30% lower, respectively, in the former group: those findings were associated with greater symptom burden in daily life and at a given exercise intensity (leg discomfort and dyspnoea). The low ΔV'O2 /ΔWR group presented with other evidences of impaired aerobic function (sluggish V'O2 kinetics, earlier anaerobic threshold) and cardiocirculatory performance (lower oxygen pulse, lower stroke volume and cardiac output) (p<0.05). Despite similar exertional hypoxaemia, they showed worse ventilatory inefficiency and higher operating lung volumes, which led to greater mechanical inspiratory constraints (p<0.05).Impaired aerobic function due to negative cardiopulmonary-muscular interactions is an important determinant of exercise intolerance in patients with COPD-HF. Treatment strategies to improve oxygen delivery to and/or utilisation by the peripheral muscles might prove particularly beneficial to these patients.
引用
- Rocha A, Arbex FF, Sperandio PA, et al. Exercise intolerance in comorbid COPD and heart failure: the role of impaired aerobic function. Eur Respir J. 2019. PMID: 30765506. doi:10.1183/13993003.02386-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。